TP53 and plasma cell myeloma: In multiple myeloma cells (MM1.s), EGCG (1 and 5 μM) was shown to inhibit miRNA-25, miRNA-92, miRNA-141, and miRNA-200a, all being implicated in p53 targeting reduction, a hallmark of multiple myeloma [215].